Transfusion

• 

  Publication Venue For

  • Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review..  59:1870-1879. 2019
  • Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery..  59:1209-1222. 2019
  • A whole genome approach for discovering the genetic basis of blood group antigens: independent confirmation for P1 and Xga..  59:908-915. 2019
  • Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism..  58:2797-2806. 2018
  • Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion..  58:2290-2296. 2018
  • Analysis of a large data set to identify predictors of blood transfusion in primary total hip and knee arthroplasty..  58:1855-1862. 2018
  • Metabolomics evaluation of early-storage red blood cell rejuvenation at 4°C and 37°C..  58:1980-1991. 2018
  • Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016..  58:255-266. 2018
  • Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure..  57:2159-2163. 2017
  • Encouraging single-unit transfusions: a superior patient blood management strategy?.  57:1107-1108. 2017
  • A randomized controlled pilot study of VO2 max testing: a potential model for measuring relative in vivo efficacy of different red blood cell products..  57:630-636. 2017
  • Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States..  57:289-295. 2017
  • Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers..  57:207-214. 2017
  • Anti-Jka that are detected by solid-phase red blood cell adherence but missed by gel testing can cause hemolytic transfusion reactions..  56:2973-2979. 2016
  • How transplant centers deal with the dextran shortage: recommendations for comparing alternatives..  56:2657-2661. 2016
  • Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products..  56:2889-2894. 2016
  • Inventory management strategies that reduce the age of red blood cell components at the time of transfusion..  56:1758-1762. 2016
  • No association between donor age and recipient outcomes: transfusion of plasma in patients undergoing coronary artery bypass grafting surgery..  56:1723-1729. 2016
  • Class I and II HLA antibodies in pediatric patients with thalassemia major..  56:878-884. 2016
  • How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost?.  56:297-303. 2016
  • Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study..  55:2791-2798. 2015
  • Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity..  55:2452-2463. 2015
  • Alloimmunization in sickle cell disease: Changing antibody specificities and association with chronic pain and decreased survival.  55:1378-1387. 2015
  • Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival..  55:1378-1387. 2015
  • Erratum: Evaluation and management of postpartum hemorrhage: Consensus from an international expert panel (Transfusion (2014) 54 (1756-1768)).  55:691. 2015
  • Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity.  55:2452-2463. 2015
  • Similar dynamics of intraapheresis autologous CD34+ recruitment and collection efficiency in patients undergoing mobilization with or without plerixafor.  54:3131-3137. 2014
  • Jehovah's Witnesses and cardiac surgery: a single institution's experience..  54:2745-2752. 2014
  • Randomized study of washing 40- to 42-day-stored red blood cells..  54:2544-2552. 2014
  • Evaluation and management of postpartum hemorrhage: consensus from an international expert panel..  54:1756-1768. 2014
  • In reply..  54:1443-1444. 2014
  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.  54:306-315. 2014
  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia..  54:306-315. 2014
  • In reply..  54:496. 2014
  • Increase the quality of banked cord blood units without limiting HLA diversity: how cord blood banks could face this dilemma.  54:495-496. 2014
  • Optimizing donor selection for public cord blood banking: Influence of maternal, infant, and collection characteristics on cord blood unit quality.  54:340-352. 2014
  • Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality..  54:340-352. 2014
  • Acquired peanut hypersensitivity after transfusion..  54:256-257. 2014
  • Evaluation and management of postpartum hemorrhage: Consensus from an international expert panel.  54:1756-1768. 2014
  • Fibrinogen as a therapeutic target for bleeding: A review of critical levels and replacement therapy.  54:1389-1405. 2014
  • Randomized study of washing 40-to 42-day-stored red blood cells.  54:2544-2552. 2014
  • Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.  54:1348-1357. 2014
  • Comparison of visually estimated blood loss with direct hemoglobin measurement in multilevel spine surgery..  53:2790-2794. 2013
  • Protamine-induced immune thrombocytopenia..  53:2158-2163. 2013
  • Comparison of visually estimated blood loss with direct hemoglobin measurement in multilevel spine surgery.  53:2790-2794. 2013
  • Practical coagulation for the blood banker 2013
  • Practical coagulation for the blood banker.  53:1594-1602. 2013
  • Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion 2013
  • Transfusion-related biologic effects and free hemoglobin, heme, and iron.  53:732-740. 2013
  • Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers..  52:2459-2464. 2012
  • Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis.  52:2375-2381. 2012
  • In reply.  52:1594-1595. 2012
  • Seasonal association of thrombotic thrombocytopenic purpura..  52:1530-1534. 2012
  • A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery..  52:14-22. 2012
  • Increased numbers of total nucleated and CD34+ cells in blood group O cord blood: An analysis of neonatal innate factors in the Korean population.  52:76-81. 2012
  • In reply.  51:1125-1125. 2011
  • Storage age of transfused platelets and outcomes after cardiac surgery..  50:2311-2317. 2010
  • Blood banks, biobanks, and the ethics of donation..  50:1866-1869. 2010
  • Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders..  50:1980-1987. 2010
  • Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease..  48:917-924. 2008
  • Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions.  48:1971-1980. 2008
  • How we approach an apheresis request for a Category III, Category IV, or noncategorized indication..  47:1963-1971. 2007
  • Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation.  47:1725-1732. 2007
  • Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system..  47:680-686. 2007
  • The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients..  47:573-581. 2007
  • Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank..  46:2063-2070. 2006
  • Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulation..  46:1130-1137. 2006
  • The Lutheran glycoprotein: a multifunctional adhesion receptor..  46:668-677. 2006
  • Aprotinin versus tranexamic acid: The controversy continues.  46:319-320. 2006
  • Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: Review of safety profile.  46:919-933. 2006
  • Comparison of cytomegalovirus polymerase chain reaction and serology for screening umbilical cord blood components..  45:1722-1728. 2005
  • Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab..  45:1481-1486. 2005
  • Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report..  45:856-866. 2005
  • Results of the cord blood transplantation (COBLT) study unrelated donor banking program..  45:842-855. 2005
  • Hemostatic agents..  44:58S-62S. 2004
  • Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system..  44:1656-1662. 2004
  • Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes..  44:1143-1148. 2004
  • Erratum: Identification of the Kn^a /Kn^b polymorphism and a method for Knops genotyping (Transfusion (2004) 44 (164-169)).  44:799-800. 2004
  • Identification of the Kna/Knb polymorphism and a method for Knops genotyping..  44:164-169. 2004
  • Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens..  44:229-238. 2004
  • Increased transmigration of G-CSF-mobilized peripheral blood CD34+ cells after overnight storage at 37oC.  43:1575-1586. 2003
  • Nitric oxide in RBCs..  42:1603-1609. 2002
  • The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public..  42:669-678. 2002
  • In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter..  41:1373-1377. 2001
  • An unusual Rh antibody apparently reactive with an epitope encoded by RHD exon 2.  41:10S-10S. 2001
  • Antibodies exhibiting dosage in gel.  41:107S-107S. 2001
  • The use of polyethylene glycol in adsorptions: More evidence that antibodies may be missed.  41:30S-30S. 2001
  • Coagulation factor XI is present in intravenous immunoglobulin (IVIG) preparations.  39:99S-99S. 1999
  • Management of massive delayed hemolytic transfusion reactions in patients with sickle cell disease..  39:97S-97S. 1999
  • Large-scale use of red blood cell units containing alloantibodies..  38:69S-69S. 1998
  • Banking and transplantation of unrelated donor umbilical cord blood: status of the National Heart, Lung, and Blood Institute-sponsored trial..  38:807-809. 1998
  • Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection..  38:419-423. 1998
  • Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yields..  37:1218. 1997
  • Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction..  37:904-909. 1997
  • Erythroid-specific regulation of the CD44 in antigen gene promoter..  36:S189-S189. 1996
  • Expression of human blood group antigens by human and murine cell lines..  36:S190-S190. 1996
  • Thrombocytopenia in allogeneic peripheral blood stem cell collections..  36:668-669. 1996
  • D, weak D (Du), and partial D: the molecular story unfolds..  36:97-100. 1996
  • Patients' attitudes regarding out-of-hospital blood transfusion..  36:140-143. 1996
  • JMH variants: serologic, clinical, and biochemical analyses in two cases..  35:925-930. 1995
  • ACANTHOCYTOSIS ASSOCIATED WITH PARTIAL CD44 DEFICIENCY.  35:S238-S238. 1995
  • AN ANTI-JMH CAUSING IN-VIVO RED-CELL DESTRUCTION.  35:S86-S86. 1995
  • DOMBROCK PROTEIN - A MONOCYTE ACTIVATION MARKER.  35:S182-S182. 1995
  • LEUKOCYTE PHENOTYPIC CHANGES IN AN IN-VITRO MODEL OF ABO HEMOLYTIC TRANSFUSION REACTION.  35:S185-S185. 1995
  • Comparison of hematopoietic progenitor cells in human umbilical cord blood collected from neonatal infants who are small and appropriate for gestational age..  35:587-591. 1995
  • Evidence that CDw108 membrane protein bears the JMH blood group antigen..  35:566-570. 1995
  • Investigations using a novel monoclonal antibody to the glycosylphosphatidylinositol-anchored protein that carries Gregory, Holley, and Dombrock blood group antigens..  35:459-464. 1995
  • Location of WESb on decay-accelerating factor..  35:278. 1995
  • Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA..  34:986-994. 1994
  • DEMONSTRATION BY MONOCLONAL-ANTIBODY IMMOBILIZATION OF ERYTHROCYTE ANTIGENS AND DOT-BLOT THAT BOTH THE IN AND ANJW BLOOD-GROUP ANTIGENS RESIDE ON CD44.  34:S25-S25. 1994
  • EXPRESSION OF PHOSPHATIDYLINOSITOL-LINKED PROTEINS AND BLOOD-GROUP ANTIGENS IN DIABETIC-PATIENTS.  34:S63-S63. 1994
  • FURTHER EVIDENCE USING MONOCLONAL-ANTIBODY IMMOBILIZATION OF ERYTHROCYTE ANTIGENS THAT THE HY, GY(A), AND DO(B) ANTIGENS RESIDE ON THE SAME PROTEIN.  34:S25-S25. 1994
  • MOLECULAR-GENETIC BASIS OF THE IN-A/B POLYMORPHISM.  34:S62-S62. 1994
  • CHARACTERIZATION OF A MONOCLONAL-ANTIBODY THAT DETECTS AN ANTIGEN-RELATED TO GREGORY.  33:S48-S48. 1993
  • RELATIONSHIP OF THE ANWJ BLOOD-GROUP ANTIGEN TO EXPRESSION OF CD-44.  33:S48-S48. 1993
  • Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia..  33:665-670. 1993
  • The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation..  33:594-597. 1993
  • Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study Group..  33:504-508. 1993
  • MORE ABOUT USE OF THE TERM DR(B) - REPLY.  33:182-182. 1993
  • BIOCHEMICAL INVESTIGATION OF THE 2 PROTEIN SPECIES BEARING LUTHERAN ANTIGENS.  32:S48-S48. 1992
  • DIFFICULTIES IN SEPARATING 2 CELL-POPULATIONS IN A NEW CHIMERA.  32:S55-S55. 1992
  • MAPPING AND CHARACTERIZATION OF THE CRA EPITOPE OF DECAY ACCELERATING FACTOR.  32:S47-S47. 1992
  • MOLECULAR-BASIS OF REDUCED OR ABSENT EXPRESSION OF DECAY ACCELERATING FACTOR IN DR(A-) AND INAB PHENOTYPES OF CROMER BLOOD-GROUP.  32:S47-S47. 1992
  • SEROLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A JMH VARIANT PHENOTYPE.  32:S55-S55. 1992
  • THE CARTWRIGHT NEGATIVE PHENOTYPE - AN ACQUIRED PHENOMENON ASSOCIATED WITH ANTI-YTAB-LIKE ANTIBODY.  32:S18-S18. 1992
  • WHAT IS A BLOOD-GROUP ANTIGEN - REPLY.  32:493-493. 1992
  • In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation..  32:42-45. 1992
  • Reply.  32:391-391. 1992
  • An auto-anti-M causing hemolysis in vitro..  31:756-758. 1991
  • Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura..  31:752-755. 1991
  • Do white cells in stored blood components reduce the likelihood of posttransfusion bacterial sepsis?.  31:581-583. 1991
  • DELINEATION BY DIRECT SEQUENCING OF THE MUTATION IN 62 PERSONS WITH HEMOPHILIA-B AND DIRECT CARRIER TESTING IN 58 AT-RISK WOMEN.  30:281-281. 1990
  • Human red cell antigens. V. Expression of In(Lu)-related p80 antigens by recessive-type Lu(a-b-) red cells..  28:430-434. 1988
  • Fibrinogen content of low-volume cryoprecipitate..  27:356-358. 1987
  • Human red cell antigens. IV. The abnormal sialoglycoprotein of Gerbich-negative red cells..  27:309-314. 1987
  • EVIDENCE THAT WRB ANTIGEN INVOLVES INTERACTION BETWEEN BAND 3 AND GLYCOPHORIN-A.  27:534-534. 1987
  • THE MEMBRANE GLYCOPROTEIN DEFECT OF IN(LU) LU(A-B-) ERYTHROCYTES (E).  26:574-574. 1986
  • A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients..  25:116-119. 1985
  • Perioperative blood transfusion in patients with colon carcinoma.  25:392-394. 1985
  • THE MEMBRANE DEFECT OF GERBICH-NEGATIVE (GE-) ERYTHROCYTES (E).  25:464-464. 1985
  • Hemolytic transfusion reactions caused by failure of commercial antiglobulin reagents to detect complement..  16:417-420. 1976
  • Experimental transfusion reactions and disseminated intravascular coagulation produced by incompatible plasma in monkeys..  11:196-203. 1971
  • Introduction of the term “partial D”.  36:761-762.
  • Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy..  54:1389-1388. 2014
  • Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.  53:1120-1131. 2013
  • Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery?.  49:2006-2007. 2009
  • Pharmacologic methods to reduce perioperative bleeding.  48:31S-38S. 2008
  • Transfusion and hemostasis in cardiac surgery.  48:1S. 2008
  • Uses of antithrombin III concentrate in congenital and acquired deficiency states.  38:481-498. 1998
  • Automated thawing increases recovery of colony-forming units from banked cord blood unit grafts. 2018
  • Long-Term Functional Outcomes Following Hematopoietic Stem Cell Transplantation for Early Infantile Krabbe Disease 2016
  • Comparisons of Adverse Reactions During Therapeutic Apheresis: A 5 Year Experience at an Academic Medical Center 2013
  • Development of a Multiplayer, Virtual-Reality, Obstetric Hemorrhage Simulation Program 2013
  • Creation of a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Umbilical Cord Blood Potency 2011
  • Transfusion-Acquired Carboxyhemoglobinemia During Pediatric Cardiac Surgery 2010
  • Avoidance of post-thaw washing prior to transplantation of plasma depleted umbilical cord blood improves outcome in a matched pair audited analysis of 258 patients 2008
  • The association of plasma donor gender with short and long-term outcome after cardiac surgery 2008
  • Allolimmunization and clinical disease severity in sickle cell disease 2006
  • Duffy genotype is associated with sickle cell nephropathy 2006
  • Comparison of gel and polyethylene glycol for the detection of alloantibodies associated with delayed serological transfusion reactions 2005
  • Delayed serological transfusion reactions and the gel test: A five year experience 2005
  • Establishing an external proficiency testing program for cord blood banks: A national marrow donor program cord blood committee study 2005
  • Ex vivo expansion of gamma delta-T lymphocytes from melanoma patients and healthy control donors 2005
  • Kidd antigen suppression and production of anti-Jk(a),-Jk3 in pregnancy: A case report 2005
  • Recipient alloimmunization against bone marrow donor red cells in an infant with severe combined immunodeficiency (SCID) 2003
  • Delayed transfusion reactions and allo- and autoantibody production in sickle cell patients following erythrocytapheresis. 2002
  • Nucleic acid testing for cytomegalovirus in umbilical cord blood plasma and stem cell components 2002
  • Plasma exchange in the treatment of recurrent focal segmental glomerulosclerosis (FSGS) following renal transplant 2000